本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Amphastar Pharmaceuticals

25.99
+0.47001.84%
盘前25.990.00000.00%07:00 EDT
成交量:35.92万
成交额:927.52万
市值:12.25亿
市盈率:9.40
高:26.02
开:25.76
低:25.53
收:25.52
数据加载中...
2024/08/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/09

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/07

重要事件披露

Form 8-K - Current report
2024/07/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/06/04

重要事件披露

Form 8-K - Current report
2024/06/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/05/10

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/08

重要事件披露

Form 8-K - Current report
2024/05/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/06

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/03/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/29

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/29

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/02/28

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]